Hazel Crest, Illinois Clinical Trials

A listing of Hazel Crest, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 126 clinical trials
A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

This study is done to see if semaglutide has an effect on walking ability compared with placebo (dummy medicine) in people with peripheral arterial disease (PAD) and type 2 diabetes. Participants will either get semaglutide or placebo ("dummy") medicine - which treatment participants get is decided by chance. Semaglutide is …

pain-free
intermittent claudication
diabetes
Novo Nordisk Investigational Site
 (9.2 away) Contact site
  • 0 views
  • 25 Sep, 2021
  • +111 other locations
Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone

The main objective of this study is to evaluate the efficacy of SZC as compared with placebo in keeping potassium levels within the normal range (3.5-5.0 mEq/L) while on spironolactone 25 mg daily without assistance of rescue therapy for hyperkalaemia (HK).

Research Site
 (14.9 away) Contact site
  • 0 views
  • 29 Aug, 2021
  • +52 other locations
Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)

Hepatitis C Virus (HCV) infection is a global health problem. HCV mainly affects liver cells and causes the liver to become inflamed and damaged. This study will evaluate how safe and effective glecaprevir/pibrentasvir (GLE/PIB) is in adult and adolescent participants with acute HCV infection. GLE/PIB is an approved drug for …

Franciscan Health Munster /ID# 231618
 (9.2 away) Contact site
  • 0 views
  • 26 Sep, 2021
  • +56 other locations
Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure Obesity and Type 2 Diabetes

This study will look at how participants' daily life is affected by their heart failure. The study will also look at the change in participants' body weight. This study will compare the effect of semaglutide (a new medicine) compared to "dummy" medicine on body weight and heart failure symptoms. Participants …

Novo Nordisk Investigational Site
 (37.1 away) Contact site
  • 7 views
  • 26 Sep, 2021
  • +59 other locations
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

This randomized, placebo-controlled phase III trial is evaluating the benefit of rucaparib and enzalutamide combination therapy versus enzalutamide alone for the treatment of men with prostate cancer that has spread to other places in the body (metastatic) and has become resistant to testosterone-deprivation therapy (castration-resistant). Enzalutamide helps fight prostate cancer …

Ingalls Memorial Hospital
 (3.2 away) Contact site
  • 0 views
  • 22 Aug, 2021
  • +259 other locations
Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder

The study's purpose its to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compulsive Disorder (OCD)

fluvoxamine
serotonin reuptake inhibitors
clomipramine
Healthcare Research Network II, LLC
 (2.3 away) Contact site
  • 19 views
  • 02 Sep, 2021
  • +89 other locations
CHAMPION-AF Clinical Trial

The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.

vascular disease
fibrillation
noac
vitamin k
left atrial appendage closure
Community Hospital
 (9.6 away) Contact site
  • 0 views
  • 26 Sep, 2021
  • +92 other locations
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

This is a study in adults who had a heart attack (myocardial infarction). The purpose of this study is to find out whether a medicine called empagliflozin helps to lower the chances of having to go to the hospital for heart failure and whether it lowers the chances of dying …

atherosclerosis
st elevation myocardial infarction
myocardial infarction
revascularisation
cardiovascular disease
Cardiovascular Research of Northwest Indiana, LLC
 (9.6 away) Contact site
  • 0 views
  • 26 Sep, 2021
  • +237 other locations
Global Prevalence of ATTR-CM in Participants With HFpEF

This study is a global, multi-center study designed to estimate the global prevalence of transthyretin amyloid cardiomyopathy (ATTR-CM) within a clinically at risk population [participants with heart failure with preserved ejection fraction (HFpEF)].

Huntsville Hospital
 (474.6 away) Contact site
  • 0 views
  • 20 Sep, 2021
  • +23 other locations
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical …

Ingalls Memorial Hospital
 (3.2 away) Contact site
  • 6 views
  • 12 Sep, 2021
  • +368 other locations